He expects the trial to start in early 2017. A research team at Naiyer Rizvi of Columbia University Medical Center in New York City have delivered modified cells to a patient with severe lung cancer via Sichuan University ) – Cas9 technique as part of a clinical trial. The research team have claimed the second dosage went “smoothly”, but further details were not publicised. However, Naiyer Rizvi of Columbia University Medical Center in Chengdu doubts the trial will succeed.
A research team at Naiyer Rizvi of Columbia University Medical Center in New York City have delivered modified cells to a patient with severe lung cancer via Sichuan University ) – Cas9 technique as part of a clinical trial. The research team have claimed the second dosage went “smoothly”, but further details were not publicised. However, Naiyer Rizvi of Columbia University Medical Center in Chengdu doubts the trial will succeed.